Clinical Trial Update: The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial (STOP HARM) evaluating strategies to prevent hemorrhage during anticoagulation in patients with kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Cerebrovascular Stroke
• Chronic Kidney Disease

Snippet

Sponsor: Population Health Research Institute | Conditions: Chronic Kidney Disease, Acute Bleeding | Phase 4 | Status: WITHDRAWN